Navigation Links
Wall's To Develop Low-fat Ice-cream Using Fish Blood

Wall's have announced their plans to use a protein that has been originally isolated from fish blood to produce the world's first ice creams using genetically// modified technology.

The parent company, Unilever, have claimed that the technique will allow it them to develop ice creams that are of low-calorie, and low fat. They explained that they could be using this technology to make newer versions of their best selling products like the Cornetto, Magnum, and Carte D'Or.

There are debates going on about the GM technology due to an increased desire by consumers for a more natural 'real' food diet, where in artificial additives are removed. But officials at the Unilever believe the benefits of low-fat ice cream could prevail over any doubts about GM.

It was explained that the blood protein is originally extracted from an eel-like ocean pout fish, which uses the protein to survive extreme cold at the bottom of the seas. They stated that the protein has been chemically synthesised and it can be grown in vast vases that can produce a brownish liquid. This liquid, they explained could lower the lowers the temperatures at which ice crystals form and the shape they take up. They claimed that they could then create a stiff and solid mixture by using less cream or fat.

The company has also announced that they have submitted an application with the Food Standard Agency to use the new technology, involving the GM process. Unilever officials have also stated that the process has already been approved in the U.S. and in other parts of the world. They categorically stated that no GM material would remains in the final product, and that the process involving the GM element would be used to only create the protein.

Clare Oxborrow a food campaigner of the Friends of the Earth has said: 'At a time when more and more consumers want to choose unadulterated food, it's disappointing to see Unilever investing in this unnecessa ry development in overly processed food.'


'"/>




Related medicine news :

1. Developmental, neurologic problems common in extremely preterm infants
2. Development of AIDS vaccine -- Chiron Corp in talks with four Indian cos
3. Risk Of Developing Arthritis
4. Developing HIV fighter
5. Missing Protein In Cancer Development
6. Tomatoes Might Inhibit the Development Of Prostate Cancer
7. Antibiotics Found To Increase The Risk Of Developing Breast Cancer
8. The Effectiveness Of Cancer Drug In Women At Risk Of Developing Cancer
9. Men Who at Risk Of Developing Prostate Cancer
10. Identifying The Risks Of Developing Schizophrenia
11. Patients With Severe Hemophilia At Risk Of Developing Osteoporosis
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... Oklahoma City, Oklahoma (PRWEB) , ... June 25, ... ... to helping both athletes and non-athletes recover from injury. Recently, he has implemented ... for the Oklahoma City area —Johnson is one of the first doctors to ...
(Date:6/25/2016)... , ... June 25, 2016 , ... Conventional wisdom preaches ... success. In terms of the latter, setting the bar too high can result in ... than just slow progress toward their goal. , Research from PsychTests.com ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic ... many turn to unhealthy avenues, such as drug or alcohol abuse, as a coping ... released tools for healthy coping following a traumatic event. , Trauma sufferers tend to ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Marcy was in a crisis. Her son James, ... out at his family verbally and physically. , “When something upset him, he couldn’t control ... use it. He would throw rocks at my other children and say he was going ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg ... Legal Elite. The attorneys chosen by their peers for this recognition are considered among ... Greenberg Traurig Shareholders received special honors as members of this year’s Legal Elite Hall ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016  Global Blood Therapeutics, Inc. (GBT) (NASDAQ: ... novel therapeutics for the treatment of grievous blood-based ... closing of its previously announced underwritten public offering ... public offering price of $18.75 per share. All ... by GBT. GBT estimates net proceeds from the ...
(Date:6/24/2016)... Dehaier Medical Systems Ltd. (NASDAQ: DHRM ) ... medical devices and wearable sleep respiratory products in ... with Hongyuan Supply Chain Management Co., Ltd. (hereinafter referred ... to develop Dehaier,s new Internet medical technology business. ... Hongyuan Supply Chain,s sales platform to reach Dehaier,s dealers ...
(Date:6/24/2016)... NAMUR , Belgium , ...  (NYSE MKT: VNRX), today announced the appointment of ... Board of Directors as a Non-Executive Director, effective ... the Company,s Audit, Compensation and Nominations and Governance ... Board, Dr. Futcher will provide independent expertise and ...
Breaking Medicine Technology: